Epilepsy: Seizures, Diagnosis, Treatment, and Living Safely

A patient guide to epilepsy — seizure types, how epilepsy is diagnosed, medications, triggers, driving safety, and what to do during a seizure.

Intro

Epilepsy is one of the world’s most common neurological conditions, affecting approximately 50 million people globally. It is characterised by a tendency to have recurrent, unprovoked seizures — episodes of abnormal electrical activity in the brain that temporarily disrupt normal function.

Epilepsy is not a single disease. It is a spectrum of conditions with different seizure types, causes, severities, and outcomes. Many people with epilepsy achieve excellent seizure control and live full, active lives. Understanding the condition — including how to manage it, what to avoid, and how to stay safe — is central to living well.


Key Points

  • Epilepsy affects approximately 50 million people worldwide; about 1 in 26 people will develop it at some point in their life
  • Seizures vary enormously — from brief blank stares to generalised convulsions
  • Diagnosis requires clinical assessment, EEG, and often brain MRI
  • Most people achieve seizure control with one or two antiseizure medications
  • Seizure triggers (sleep deprivation, alcohol, stress, illness) should be identified and managed
  • Driving restrictions apply in most countries during periods of uncontrolled seizures
  • SUDEP — sudden unexpected death in epilepsy — is rare but can be reduced by optimising seizure control

Background: What Causes Seizures?

The brain communicates via electrical signals. A seizure occurs when abnormal, excessive, or hypersynchronous electrical activity disrupts normal function — either in one brain region or across the whole brain.

Causes of epilepsy include

  • Structural: brain lesions from stroke, tumour, traumatic brain injury, cortical malformations
  • Genetic: many epilepsy syndromes have identified genetic mutations (ion channel genes, etc.)
  • Metabolic: low sodium, low glucose, low calcium, thyroid disorders
  • Autoimmune: autoimmune encephalitis (anti-NMDA receptor, LGI1, CASPR2 antibodies)
  • Infectious: meningitis, encephalitis, cerebral abscess
  • Unknown (cryptogenic): no identifiable cause despite investigation — the most common category in adults

Types of Seizures

The ILAE (International League Against Epilepsy) classifies seizures by how they begin:

Focal-onset seizures (arising from one brain region)

  • Focal aware (previously “simple partial”): person remains conscious; may experience tingling, visual disturbances, déjà vu, rising stomach sensation, fear, or abnormal movements confined to one body part
  • Focal impaired awareness (previously “complex partial”): consciousness is altered; may involve automatisms — repetitive semi-purposeful movements like lip-smacking, chewing, hand-rubbing; person may appear confused or dazed
  • Focal to bilateral tonic-clonic: a focal seizure that spreads to become a generalised convulsion

Generalised-onset seizures (involving both hemispheres simultaneously)

  • Tonic-clonic (“grand mal”): loss of consciousness, stiffening (tonic phase), followed by rhythmic jerking (clonic phase); usually 1–3 minutes, followed by postictal confusion and fatigue
  • Absence (“petit mal”): brief (5–30 second) blank staring, unresponsiveness; may involve eye blinking or subtle automatisms; common in childhood epilepsy syndromes
  • Myoclonic: sudden, brief muscle jerks — often affect arms; can cause objects to fly from hands; common on awakening
  • Tonic: sudden muscle stiffening, may cause falls
  • Atonic (“drop attacks”): sudden loss of muscle tone causing falls
  • Clonic: rhythmic jerking without preceding tonic phase

Unknown onset

Some seizures cannot be classified due to limited information about onset.


Diagnosis

Clinical history

The most important diagnostic tool is a detailed account of what happened — ideally from a witness as well as the patient. Neurologists assess: what the person was doing before, early sensations (aura), what the seizure looked like, duration, recovery time, and any incontinence or tongue biting.

Electroencephalogram (EEG)

An EEG records electrical brain activity via scalp electrodes. EEG can:

  • Identify abnormal epileptiform discharges (spikes, sharp waves) that support an epilepsy diagnosis
  • Help classify seizure type and epilepsy syndrome
  • Guide medication selection

A normal EEG does not exclude epilepsy — EEG has significant limitations. Prolonged EEG monitoring and video-EEG (simultaneous EEG and video recording of a seizure) improve diagnostic yield.

Brain MRI

Standard investigation for newly diagnosed epilepsy. Identifies structural causes (tumour, mesial temporal sclerosis, cortical dysplasia, vascular lesions). High-resolution epilepsy-protocol MRI is preferred.

Blood tests

Glucose, electrolytes, calcium, liver and kidney function, full blood count — to exclude metabolic causes of acute seizures and baseline values before medication.

Additional tests when indicated

  • Video-EEG telemetry: inpatient recording of actual seizures with simultaneous EEG — the gold standard for diagnosis and pre-surgical evaluation
  • Autoimmune encephalitis panel: if autoimmune cause suspected
  • Genetic testing: in unexplained epilepsy, particularly in children or with a family history

Antiseizure Medications (ASMs)

The goal of antiseizure medication is seizure freedom with acceptable side effects. About 70% of people with epilepsy achieve seizure control with medication.

Starting treatment

Treatment is generally started after two unprovoked seizures, or after one seizure when recurrence risk is high. The first medication chosen depends on seizure type, epilepsy syndrome, age, sex, and other medical factors.

Commonly used medications

MedicationCommon usesKey considerations
LevetiracetamFocal, generalisedWidely used; can cause irritability/mood change
LamotrigineFocal, generalisedRequires slow titration; preferred in women of childbearing age
ValproateGeneralised (especially absence, JME)Highly effective; significant teratogen — avoid in women who may become pregnant
CarbamazepineFocalEffective; multiple drug interactions
LacosamideFocalWell tolerated; fewer interactions
EthosuximideAbsence seizures onlyFirst-line for pure absence
ZonisamideFocal, generalisedOnce-daily dosing; weight neutral
TopiramateFocal, generalisedCognitive side effects; causes weight loss
BrivaracetamFocalFewer behavioural side effects than levetiracetam
PerampanelFocal, generalised tonic-clonicOnce daily; aggression/mood risk

Drug-resistant epilepsy

Defined as failure of two appropriately chosen and tolerated ASMs. Approximately 30% of people with epilepsy do not achieve seizure freedom with medication. These patients should be referred to an epilepsy specialist or comprehensive epilepsy programme for further evaluation, including consideration of surgery.


Epilepsy Surgery

For carefully selected patients with drug-resistant focal epilepsy, surgery can be curative or substantially improve seizure control.

  • Temporal lobectomy (for mesial temporal lobe epilepsy): seizure freedom in 60–70% of carefully selected patients
  • Lesionectomy: removal of a structural lesion causing seizures
  • Laser ablation (LITT): minimally invasive thermal ablation of seizure focus
  • Corpus callosotomy: reduces spread of seizures; used for drop attacks
  • Vagus nerve stimulation (VNS): implantable device that reduces seizure frequency in drug-resistant epilepsy; not curative but adjunctive
  • Responsive neurostimulation (RNS): closed-loop brain stimulation device that detects and interrupts seizure activity

Seizure Triggers

Identifying and managing personal triggers can significantly reduce seizure frequency:

  • Sleep deprivation — one of the most consistent triggers across epilepsy types; prioritise sufficient, regular sleep
  • Alcohol — lowers seizure threshold; binge drinking is particularly high-risk
  • Missed medication — the most common preventable cause of breakthrough seizures
  • Fever and illness — particularly in febrile-prone epilepsy syndromes
  • Stress — indirect trigger through sleep disruption and physiological arousal
  • Hormonal changes — some women experience catamenial epilepsy (seizure clustering around menstruation)
  • Flashing lights (photosensitive epilepsy) — affects ~3% of people with epilepsy; generalised epilepsies most commonly

A seizure diary helps identify personal patterns.


Safety Considerations

What to do during a seizure (for bystanders)

  1. Stay calm; note the time the seizure starts
  2. Protect from injury — move hard objects away; cushion the head
  3. Do not restrain movements
  4. Do not put anything in the person’s mouth — there is no risk of “swallowing the tongue”
  5. Once convulsive movements stop, roll into the recovery position (on their side)
  6. Stay with the person until fully recovered

Call an ambulance if:

  • The seizure lasts more than 5 minutes (or longer than their usual seizures)
  • Another seizure follows without full recovery
  • The person is injured or not breathing after the seizure
  • This is the person’s first known seizure
  • You are uncertain whether recovery is complete

Home safety

  • Showering rather than bathing (drowning risk)
  • Padding sharp furniture corners
  • Cooking on back hob rings
  • Avoiding working at heights or near open water without safeguards

Work and activity

Most people with well-controlled epilepsy can work across a wide range of occupations. High-risk roles (working at heights, operating heavy machinery, certain transport roles) require specific assessment.


Driving

Driving with uncontrolled epilepsy poses significant safety risk. Most countries have laws that restrict driving:

  • Most jurisdictions require a seizure-free period (commonly 6 or 12 months) before a licence can be held or regained
  • Rules vary for different licence types (car, heavy vehicle, motorcycle)
  • Reporting obligations vary — check your local licensing authority and seek specialist advice

Your treating neurologist can advise on current guidelines applicable to your situation.


SUDEP: Sudden Unexpected Death in Epilepsy

SUDEP is a rare complication in which a person with epilepsy dies suddenly and unexpectedly without an identified cause. It is most commonly associated with uncontrolled convulsive seizures and nocturnal seizures.

The annual risk is approximately 1 in 1,000 people with epilepsy — placing it in perspective as rare, but not negligible. Risk is substantially lower in those with well-controlled seizures.

Risk reduction strategies:

  • Optimise seizure control — medication adherence, specialist review, considering surgery if appropriate
  • Avoid seizure triggers — particularly sleep deprivation and alcohol
  • Nocturnal monitoring — for those with nocturnal seizures, listening monitors or specialist seizure detection devices may be discussed with a neurologist
  • Not sleeping alone when seizure risk is high — particularly for high-risk individuals

SUDEP should be discussed openly between patients, families, and clinicians — awareness enables risk reduction without creating unnecessary fear.


Women and Epilepsy

Women with epilepsy require additional consideration in several areas:

  • Contraception: some ASMs (enzyme-inducing drugs like carbamazepine, phenytoin) reduce the effectiveness of hormonal contraception; specialist advice is essential
  • Pregnancy: most women with epilepsy have healthy pregnancies; folate supplementation is recommended before conception; valproate is teratogenic and must not be used in women who may become pregnant without compelling specialist justification
  • Catamenial epilepsy: seizure clustering with the menstrual cycle; may respond to hormonal or medication strategies

Mental Health and Epilepsy

Depression and anxiety are approximately two to three times more common in people with epilepsy than the general population. This is partly biological (shared brain mechanisms), partly due to the burden of living with an unpredictable condition.

Mental health should be actively assessed and treated — not accepted as inevitable. See Depression and Anxiety for evidence-based management options.


Further Reading